Akceso’s ‘Evidence-based Asset Valuation’ methodology
What the three-part evidence-gathering method includes and how it helps to achieve both patient- & public health benefit and long-term economic success.
Establish a trusted basis for competitive analyses and statutory price certification with our up-to-date, industry leading database of pharmaceutical prices and reimbursement conditions across portfolios and countries. It provides vastly better coverage than alternative offerings.
What the three-part evidence-gathering method includes and how it helps to achieve both patient- & public health benefit and long-term economic success.
“I am really pleased with the outcome…. and seldom agree so quickly with
Get in touch with us and schedule a demo.
Error: Contact form not found.
The PRiMA Headlines Newsletter provides a monthly overview of developments in Pricing, Reimbursement and Market Access developments across the globe. Since its launch in June 2015 we have covered more than 5,000 stories from over 100 countries.